Maïté Daroux

Intracellular Nucleic Acid Sensors and Autoimmunity

Intensive versus conventional glycaemic control for treating diabetic foot ulcers

Oxidative stress, aging, and diseases

Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease

Cellular and molecular mechanisms of renal fibrosis

Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?

Treatment of chronic kidney disease

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

NAFLD: A multisystem disease

Update on management of diabetic foot ulcers

Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review

Fibrosis — A Common Pathway to Organ Injury and Failure

Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes

Mechanisms of Diabetic Complications

Complement C3a, CpG Oligos, and DNA/C3a Complex Stimulate IFN-α Production in a Receptor for Advanced Glycation End Product-Dependent Manner

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases

Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies

Kidney, heart and brain: three organs targeted by ageing and glycation